Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
75.80
Ask:
77.20
Spread: 1.40 (1.847%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Director/PDMR Shareholding

3 Jan 2012 14:08

RNS Number : 9109U
Accsys Technologies PLC
03 January 2012
 



 

 

AIM: AXS

NYSE Euronext Amsterdam: AXS

3 January 2012

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Directors and Persons Discharging Managerial Responsibilities' Interests

 

Accsys, the environmental science and wood technology company, announces in compliance with the AIM Rules and Disclosure and Transparency Rulesthat all 2,500,000 ordinary shares of €0.01 in the Company ("Ordinary Shares") held by the Accsys Employee Benefit Trust ('EBT') (established in February 2011) vested on 31 December 2011 and have been released to the beneficiaries of the EBT, being those executive directors and certain persons discharging managerial responsibilities whose names are set out below (the "Beneficiaries").

 

As announced on 4th February 2011, such Ordinary Shares were issued to the EBT in connection with employee remuneration and incentivisation arrangements and vest upon payment by the Beneficiaries of the nominal value of €0.01 per Ordinary Share. The market value of the Ordinary Shares at the date of vesting was €0.11 per Ordinary Share.

 

Certain individuals subsequently elected to immediately sell a number of shares on the open market for the reasons set out below. These shares were sold at price of €0.1175 per Ordinary Share.

 

Name Number of Ordinary Number of Ordinary

Shares Vested Shares subsequently

sold on open market Note

 

Paul Clegg 750,000 Nil (i)

Hans Pauli 500,000 299,410 (ii)

Edward Pratt 250,000 Nil

Michel Maes 250,000 250,000 (ii)

Hal Stebbins 250,000 Nil

William Rudge 250,000 117,803 (iii)

Angus Dodwell 250,000 117,803 (iv)

 

 

Notes:

(i) Shares will be sold and immediately repurchased by Individual Savings Account ('ISA') in the name of the individual.

(ii) Shares have been sold to allow proceeds to be invested in personal pension fund.

(iii) Shares sold to pay for nominal value and resulting personal tax liability.

(iv) Shares sold to pay for nominal value and resulting personal tax liability. Balance of shares will be sold and immediately repurchased by ISA in the name of the individual.

Ends

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Hans Pauli, CFO

 via Citigate Dewe Rogerson

Numis Securities

Nominated Adviser: Oliver Cardigan

Corporate Broking: Christopher Wilkinson

Ben Stoop

 

+44 (0)20 7260 1000

 

Citigate Dewe Rogerson

Chris Gardner

Malcolm Robertson

Suzanne Bakker

 

+44 20 7282 2995

+44 20 7282 2867

+31 20 575 4023

 

Notes to Editors:

Accsys Technologies PLC(www.accsysplc.com) is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its 100% owned subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands, a European office in London and an American office in Dallas, Texas. Accsys Technologies PLC is listed on the London Stock Exchange AIM market, and on Euronext Amsterdam by NYSE Euronext, under the symbols 'AXS'. Accsys' operations comprise three principal business units: (i) the Accoya® wood production facility; (ii) technology development, focused on a programme of continuous improvements to the process engineering and operating protocols for the acetylation of wood which are currently under development and the development of technology for the acetylation of wood elements; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. The process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

Accoya® wood (www.accoya.com) is produced using a process, the subject of patent applications around the world, that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most tropical and European hardwoods, its colour does not degrade when exposed to ultraviolet light. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. For marine uses where weight is also important, Accoya® wood for the first time provides boat builders with a wood that is strong, lightweight, durable and retains its natural beauty for far longer. For a full archive of Accoya® news, visit www.accoya.com/news.asp.

Tricoya® wood Elements (www.tricoya.com) is Titan Wood's proprietary technology for the acetylation of wood chips, and particles for use in the fabrication of wood based composites, including panel products. These composites demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Tricoya® Wood Elements is lauded as the first major innovation in the wood composites industry in more than 30 years.

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSZXLFBLFFBBBD
Date   Source Headline
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSTotal Voting Rights
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.